Literature DB >> 8849248

Effects of inhibitors of protein synthesis on lysis of Escherichia coli induced by beta-lactam antibiotics.

D G Rodionov1, E E Ishiguro.   

Abstract

The role of protein synthesis in ampicillin-induced lysis of Escherichia coli was investigated. The inhibition of protein synthesis through amino acid deprivation resulted in the rapid development of ampicillin tolerance as a consequence of the stringent response, as previously reported. In contrast, inhibition of protein synthesis by use of ribosome inhibitors such as chloramphenicol did not readily confer ampicillin tolerance and, in fact, promoted the development of both stages of the ampicillin-induced lysis process, i.e., (i) an ampicillin-dependent stage which apparently involves the interaction of penicillin-binding proteins with ampicillin and (ii) an ampicillin-independent stage which may represent the events leading to the deregulation of peptidoglycan hydrolase activity. We propose that lysis was facilitated when protein synthesis was inhibited because the production of new penicillin-binding proteins to replace those which were ampicillin inhibited was prevented under these conditions.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8849248      PMCID: PMC163227     

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  14 in total

1.  The Isolation of Biochemically Deficient Mutants of Bacteria by Means of Penicillin.

Authors:  B D Davis
Journal:  Proc Natl Acad Sci U S A       Date:  1949-01       Impact factor: 11.205

2.  Lysis of nongrowing Escherichia coli by combinations of beta-lactam antibiotics and inhibitors of ribosome function.

Authors:  W Kusser; E E Ishiguro
Journal:  Antimicrob Agents Chemother       Date:  1986-03       Impact factor: 5.191

3.  Dissociation of the ampicillin-induced lysis of amino acid-deprived Escherichia coli into two stages.

Authors:  A G Pisabarro; M A De Pedro; E E Ishiguro
Journal:  J Bacteriol       Date:  1990-04       Impact factor: 3.490

4.  Involvement of the relA gene in the autolysis of Escherichia coli induced by inhibitors of peptidoglycan biosynthesis.

Authors:  W Kusser; E E Ishiguro
Journal:  J Bacteriol       Date:  1985-11       Impact factor: 3.490

5.  The rate of killing of Escherichia coli by beta-lactam antibiotics is strictly proportional to the rate of bacterial growth.

Authors:  E Tuomanen; R Cozens; W Tosch; O Zak; A Tomasz
Journal:  J Gen Microbiol       Date:  1986-05

6.  Site of inhibition of peptidoglycan biosynthesis during the stringent response in Escherichia coli.

Authors:  W D Ramey; E E Ishiguro
Journal:  J Bacteriol       Date:  1978-07       Impact factor: 3.490

7.  Induction and control of the autolytic system of Escherichia coli.

Authors:  M Leduc; R Kasra; J van Heijenoort
Journal:  J Bacteriol       Date:  1982-10       Impact factor: 3.490

8.  Direct correlation between overproduction of guanosine 3',5'-bispyrophosphate (ppGpp) and penicillin tolerance in Escherichia coli.

Authors:  D G Rodionov; E E Ishiguro
Journal:  J Bacteriol       Date:  1995-08       Impact factor: 3.490

9.  Alteration of Escherichia coli murein during amino acid starvation.

Authors:  W Goodell; A Tomasz
Journal:  J Bacteriol       Date:  1980-12       Impact factor: 3.490

10.  Beta-lactam-induced bacteriolysis of amino acid-deprived Escherichia coli is dependent on phospholipid synthesis.

Authors:  D G Rodionov; A G Pisabarro; M A de Pedro; W Kusser; E E Ishiguro
Journal:  J Bacteriol       Date:  1995-02       Impact factor: 3.490

View more
  2 in total

Review 1.  Distinguishing between resistance, tolerance and persistence to antibiotic treatment.

Authors:  Asher Brauner; Ofer Fridman; Orit Gefen; Nathalie Q Balaban
Journal:  Nat Rev Microbiol       Date:  2016-04       Impact factor: 60.633

Review 2.  Peptidoglycan hydrolases of Escherichia coli.

Authors:  Jean van Heijenoort
Journal:  Microbiol Mol Biol Rev       Date:  2011-12       Impact factor: 11.056

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.